Use of brentuximab vedotin as salvage therapy pre-allogeneic stem cell transplantation in relapsed/refractory CD30 positive lympho-proliferative disorders: a single centre experience-Reference-Cited by-同舟云学术

Use of brentuximab vedotin as salvage therapy pre-allogeneic stem cell transplantation in relapsed/refractory CD30 positive lympho-proliferative disorders: a single centre experience

Published:2017-05 Issue:5 Volume:47 Page:574-578
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Mediwake Heshani¹²^ORCID,Morris Kirk¹,Curley Cameron¹,Butler Jason¹,Kennedy Glen¹²

Affiliation:

1. Cancer Care Services; Royal Brisbane and Women's Hospital; Brisbane Queensland Australia

2. School of Medicine; University of Queensland; Brisbane Queensland Australia

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.13415/fullpdf

Reference19 articles.

1. Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse;Sureda;Ann Oncol,2005

2. Long-term results of autologous stem cell transplantation for primary refractory or relapsed Hodgkin's lymphoma;Majhail;Biol Blood Marrow Transplant,2006

3. The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma;Collins;Am J Hematol,2015

4. The biology and management of systemic anaplastic large cell lymphoma;Hapgood;Blood,2015

5. Lysosomal trafficking and cysteine protease metabolism confer target-specific cytotoxicity by peptide-linked anti-CD30-auristatin conjugates;Sutherland;J Biol Chem,2006

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of a New Risk Stratification System in Pediatric Anaplastic Large Cell Lymphoma: Result of a Prospective Open-Label Multiple-Institution Study;2023-02-20

2. Anti-CD30 antibody–drug conjugate therapy in lymphoma: current knowledge, remaining controversies, and future perspectives;Annals of Hematology;2022-12-13

3. Allogeneic Stem Cell Transplantation in Mature T Cell and Natural Killer/T Neoplasias: A Registry Study from Spanish GETH/GELTAMO Centers;Transplantation and Cellular Therapy;2021-06

4. Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC);Journal of Hematology & Oncology;2020-05-19

5. Allogeneic hematopoietic stem cell transplantation for patients with relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the Lymphoma Working Party of the European Society for Blood and Marrow Transplantation;Bone Marrow Transplantation;2019-11-06